Literature DB >> 10524337

Ultrastructural localization of the corticotropin-releasing factor-binding protein in rat brain and pituitary.

C A Peto1, C Arias, W W Vale, P E Sawchenko.   

Abstract

Preembedding immunoperoxidase staining methods were used to permit ultrastructural analyses of the distribution in rat brain and pituitary of the corticotropin-releasing factor-binding protein (CRF-BP), a moiety distinct from CRF receptors, but which is nonetheless capable of binding the peptide and reversibly neutralizing its biological actions. In anterior pituitary, CRF-BP immunoreactivity (ir) was detected in corticotropelike cells, with reaction product associated principally with secondary lysosomes and multivesicular bodies and not at all with secretory granules. In brain, marked regional differences in the subcellular pattern of CRF-BP staining were evident. In isocortex, where BP/peptide colocalization is rare, BP-ir was distributed in cells and processes in a manner similar to that of a prototypic neuropeptide, including in terminals commonly engaging in synaptic contacts with unlabeled dendritic profiles. In the bed nucleus of the stria terminalis, a site that contains overlapping accumulations of CRF-BP-ir projections and CRF-ir perikarya, BP staining was restricted to vesicle-laden varicosities that rarely engaged in synaptic contacts with somatic or dendritic elements but were frequently apposed to unlabeled axon varicosities and terminals. In the ventromedial medulla, a site of partial CRF/BP overlap, most cells displayed a subcellular localization CRF-BP-ir like that seen in cortex, whereas in others the distribution shared similarities with that observed in pituitary. The results suggest that the function of the CRF-BP may differ in different cellular contexts. In cellular targets of CRF or in neurons in which peptide and BP coexist, the CRF-BP may play a role in processing and degradation of CRF and/or ligand-receptor complexes. In other areas of the central nervous system, the BP seems positioned to serve as a transmitter/modulator at conventional synapses or as an autocrine or paracrine modulator of local CRF effects.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10524337

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  9 in total

1.  Corticotropin-releasing factor 1 and 2 receptors in the dorsal raphé differentially affect serotonin release in the nucleus accumbens.

Authors:  Jodi L Lukkes; Gina L Forster; Kenneth J Renner; Cliff H Summers
Journal:  Eur J Pharmacol       Date:  2007-10-02       Impact factor: 4.432

2.  Pituitary CRH-binding protein and stress in female mice.

Authors:  Gwen S Stinnett; Nicole J Westphal; Audrey F Seasholtz
Journal:  Physiol Behav       Date:  2015-02-27

Review 3.  Physiology, pharmacology, and therapeutic relevance of urocortins in mammals: ancient CRF paralogs.

Authors:  Eva M Fekete; Eric P Zorrilla
Journal:  Front Neuroendocrinol       Date:  2006-11-02       Impact factor: 8.606

Review 4.  Corticotropin-releasing hormone-binding protein and stress: from invertebrates to humans.

Authors:  Kyle D Ketchesin; Gwen S Stinnett; Audrey F Seasholtz
Journal:  Stress       Date:  2017-05-18       Impact factor: 3.493

5.  CRF binding protein facilitates the presence of CRF type 2α receptor on the cell surface.

Authors:  Paula G Slater; Cledi A Cerda; Luis A Pereira; María E Andrés; Katia Gysling
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-28       Impact factor: 11.205

6.  Novel Roles for CRF-Binding Protein and CRF Receptor 2 in Binge Drinking.

Authors:  Kyle D Ketchesin; Audrey F Seasholtz
Journal:  Alcohol Clin Exp Res       Date:  2015-10-28       Impact factor: 3.455

7.  Stress-induced relapse to cocaine seeking: roles for the CRF(2) receptor and CRF-binding protein in the ventral tegmental area of the rat.

Authors:  Bin Wang; Zhi-Bing You; Kenner C Rice; Roy A Wise
Journal:  Psychopharmacology (Berl)       Date:  2007-04-17       Impact factor: 4.415

8.  Decreased CRHBP expression is predictive of poor prognosis in patients with hepatocellular carcinoma.

Authors:  Hai-Bing Xia; Hui-Ju Wang; Luo-Qin Fu; Shi-Bing Wang; Li Li; Guo-Qing Ru; Xiang-Lei He; Xiang-Min Tong; Xiao-Zhou Mou; Dong-Sheng Huang
Journal:  Oncol Lett       Date:  2018-07-04       Impact factor: 2.967

Review 9.  Corticotropin releasing factor-binding protein (CRF-BP) as a potential new therapeutic target in Alzheimer's disease and stress disorders.

Authors:  Dorien Vandael; Natalia V Gounko
Journal:  Transl Psychiatry       Date:  2019-10-22       Impact factor: 6.222

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.